Craneware

CRW · AIM · Health Care · mcap £377m · 1100.0p

Craneware sells cloud software and data analytics, under the Trisus platform, that help US hospitals manage pricing, billing, drug-discount compliance and costs. Revenue is mostly recurring subscriptions.

Recent signals

Positive 30 Sep 2026

New holders Richard Griffiths and Odyssean built stakes above 5%

Both rose from below 3% to over 5% in Aug-Sep 2026 after the share price fall. 30 Sep 2026 28 Sep 2026

Positive 22 Sep 2026

Chair, CEO's pension and a NED bought shares after profit warning and cyber incident

Insider purchases in July and September 2026 at 1,054-1,173p as shares fell from over 2,000p a year earlier. 22 Sep 2026 6 Jul 2026 3 Jul 2026

Negative 21 Sep 2026

FY27 revenue reset to ARR level c.$185m; guidance cut after cyber incident

Outlook moved from growth acceleration to flat revenue, with a cost review under way. 21 Sep 2026 3 Jul 2026

Mixed 11 Jun 2025

Board rejected Bain Capital proposal at £26.50 per share in June 2025

Bain withdrew; shares now trade around 1,100p, well below the rejected price. 11 Jun 2025

Capital actions

2026-03-16 buyback programme · $25 million – Launched share buyback of up to 3,542,956 shares; completed in FY26, partly funded by RCF drawdown 16 Mar 2026
2025-09-01 debt refinancing · $100m – New unsecured three-year RCF with four banks, plus $100m accordion 1 Sep 2025
2024-09-03 buyback programme · £5m ($6.3m) – Completed share buyback programme using £5m allocated 3 Sep 2024

From the company's own announcements · not investment advice

Company filings. Not investment advice.